Jindong Xie Selected Research

Jindong Xie Research Topics

Disease

22	Neoplasms (Cancer) 04/2024 - 01/2022
10	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2022
10	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2022
7	Triple Negative Breast Neoplasms 03/2024 - 01/2021
2	Carcinogenesis 01/2022 - 01/2022
1	Epilepsy (Aura) 01/2024
1	Liver Neoplasms (Liver Cancer) 01/2024
1	Pathologic Processes 01/2024
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024
1	Genomic Instability 12/2023
1	Communicable Diseases (Infectious Diseases) 12/2023
1	Lung Neoplasms (Lung Cancer) 11/2023
1	Bone Diseases (Bone Disease) 11/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023
1	Disease Progression 01/2022
1	Parkinson Disease (Parkinson's Disease) 02/2012

Drug/Important Bio-Agent (IBA)

6	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2022
5	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2021
5	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2022
2	Circular RNAIBA 04/2024 - 01/2024
2	Transcription Factors (Transcription Factor)IBA 04/2024 - 12/2022
2	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2022
2	Docetaxel (Taxotere)FDA Link 02/2024 - 11/2022
2	BiglycanIBA 01/2023 - 01/2022
1	Apolipoproteins E (ApoE)IBA 04/2024
1	Glycogen Synthase (Synthase I)IBA 03/2024
1	Mechanistic Target of Rapamycin Complex 1IBA 02/2024
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 02/2024
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2024
1	Carrier Proteins (Binding Protein)IBA 01/2024
1	Competitive Endogenous RNAIBA 01/2024
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2024
1	Messenger RNA (mRNA)IBA 01/2024
1	MicroRNAs (MicroRNA)IBA 01/2024
1	Piwi-Interacting RNAIBA 12/2023
1	Histone ChaperonesIBA 12/2023
1	Aurora Kinase AIBA 12/2023
1	VaccinesIBA 12/2023
1	A 7 (A-7)IBA 11/2023
1	Diphosphates (Pyrophosphates)IBA 11/2023
1	Technetium Tc 99m MedronateIBA 11/2023
1	CateninsIBA 01/2023
1	Immune Checkpoint ProteinsIBA 01/2023
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2023
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2022
1	beta CateninIBA 12/2022
1	palbociclibIBA 11/2022
1	Phenobarbital (Luminal)FDA Link 11/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022
1	Indicators and Reagents (Reagents)IBA 11/2022
1	Therapeutic UsesIBA 01/2022
1	LipidsIBA 01/2022
1	Potassium Channels (Potassium Channel)IBA 01/2022
1	CytokinesIBA 01/2022
1	pyrimidineIBA 01/2022
1	N-methyladenosineIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Estrogen ReceptorsIBA 01/2021
1	human ERBB2 proteinIBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	epimedii flavoneIBA 02/2012
1	Neuroprotective AgentsIBA 02/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2012
1	Plant Preparations (Preparation, Plant)IBA 02/2012
1	Selegiline (E250)FDA LinkGeneric 02/2012
1	Nerve Growth Factors (Neurotrophins)IBA 02/2012
1	Caspase 3 (Caspase-3)IBA 02/2012
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 02/2012

Therapy/Procedure

14	Immunotherapy 04/2024 - 01/2022
10	Therapeutics 04/2024 - 01/2022
1	Adjuvant Chemotherapy 11/2022
1	Drug Therapy (Chemotherapy) 11/2022
1	Intraperitoneal Injections 02/2012